FDA Bans CFC Inhalers, Walmart Offers Low-Cost Alternative
An FDA mandate that came into effect on Dec. 31 dictates that all albuterol metered-dose asthma inhalers marketed in the U.S. must use hydrofluroalkane (HFA) propellants, as opposed to chlorofluorocarbon (CFC) propellants.
Most manufacturers, like GlaxoSmithKline (GSK) and Schering-Plough, hurried to make the transition and have increased production to ensure an adequate supply of HFA inhalers. Armstrong Pharmaceuticals has not yet done so, the FDA said.
Rescue inhalers can be costly: some HFA inhalers may sell for as much as $60 for certain brands. To make the life-saving medication affordable, Walmart is going to sell the ReliOn Ventolin HFA inhaler for $9.
Energy Manager News
- Turning Data into Knowledge–and Action
- STULZ, CoolIT Enter Data Center Cooling Pact
- Smart Grid Partnership Announced in Europe
- Wisconsin Power & Light Files for Higher Residential Base Rates, Lower Commercial Rates
- NMPRC Orders Extension in PNM Rate Case
- US Military Taking No Risks by Going Green, Saving Lives and Energy
- Affordable Housing Pushes Energy Efficiency
- Controlling Air Conditioners